24hmedi
24hmedi
More

Latest news

Introducing MiniPen2™, the smallest safety syringe with prevention of reuse available. Sizes from 0.1ml to 3ml to be used for covid-19 vaccines.

    MiniPen1™ Our first diabetes management tool!

      Welcome to MedTech Concept LLC

      MedTech Concept LLC is a med tech company based in Delaware USA focused on diabetes healthcare. 


      Our mission is to improve the health of diabetics by developing innovative medical products and exploiting the latest advances in computer software technology including artificial intelligence and collaboration technology. At launch we will be the only miniature delivery device on the market with multiple patents protecting our lead. 


      All governments worldwide are looking to reduce diabetes medical costs. We will help them achieve this goal through lower charges and improvements in diabetic healthcare. We offer a superior product at significantly lower cost, which will drive adoption among those who pay for diabetes healthcare (both individuals and governments). 


      Market research has confirmed great interest especially among travelers, the young, the active and those struggling to manage their diabetes. 

      Our diabetes management system combines the latest in digital health software with a market tested miniature therapeutic delivery device to provide real improvements in the control of diabetes.

      Introducing MiniPen2™

      The MiniPen2™ mini pen addresses the real world needs of diabetics replacing  large, cumbersome and mostly high cost Insulin devices.


      Our concept miniaturized therapeutic delivery solution MiniPen2™ will  transform the lives of hundreds of thousands of Diabetics. Due to its  low price it will be available to a far wider audience than the current  range of large and expensive auto-injectors.


      The MiniPen2™ offers diabetics an alternative to insulin pens, pumps  and syringes by providing a small, low cost and convenient solution that  provides a noticeable improvement in quality of life.


      The MiniPen2™ takes on the safety of a syringe to the next level.

      Our new safety feature lock system prevent the use for more than one time only. After the syringe have been filled with insulin or fluid, the plunger will automatically lock into the barrel and prevent usage again. This will stop the spread of viruses and infections!


      Subscribe

      Sign up to hear from us.

      Our services

      MiniPen™ mini pen

      Most existing insulin delivery systems are large, cumbersome,  indiscreet and expensive.  Early adopters of the Minipen have noticed a  huge improvement in freedom and reduced impact upon their daily lives  using the MiniPen™.


      Our business model is to create a grass roots loyal customer base that generates repeat business while targeting governments and health ministries looking to reduce the cost of diabetes care on a national scale. 

      Diabetes care

      Our mission is to make it possible to live close to a normal life with diabetes without any complications. 


      We strive to give our patients the best treatment to achieve a good HbA1c average level.

      Diabetes Management System

      Medical software synced with self tests and clinic lab tests. Overview by a central team of doctors. The MiniPen is a key component of our comprehensive InsuManage. 

      Research and Development

      Enhanced miniaturized insulin delivery systems

      • Enhanced miniaturized insulin delivery systems
      • Diabetes Management System portal & mobile app
      • Pre-diabetes online assessment test


      Future Research (Subject to Funding)

      • Miniature insulin injection devices
      • Recycling and risk waste container



      Our products

      MiniPen 1

      All orders are custom made by the requirements from the client. The miniPen 1 is available in different sizes from 10 to 100 unit. Dose gradings on the the barrel  u40, u100, u200. Needle length 4-12mm. Thickness 29 - 32 gauge. Packing in box with 100pcs. Minimum order 100.000 boxes.

      Areas of use: Insulin, Botox

      Introducing

      MiniPen 2

      The miniPen 2 is unique in the world with our patented safety feature "prevention of reuse". Available in different sizes from 10 to 100 unit. Dose gradings on the the barrel  u40, u100, u200. Needle length 4-24mm. Thickness29 - 32 gauge. Packing in box with 100pcs. Minimum order 100.000 boxes. Areas of use: Insulin

      Covid-19 Vaccine, safety syringe

      The safety syringe is encased in the holder which seals tightly against the lid and therefore extra protected against dirt and bacteria. The size can vary from 0.1 ml to 3ml, the needle is available in different lengths and thicknesses according to the customer's requirements. Minimum order 10 million pcs.

      With the MiniPen1™ you can keep on doing what you love.

      Tommy Brolin

      Ivar Frischer

      Ivar Frischer

      PhD (Tech). Patent Lawyer

      Member


       Has worked for many years as a patent agent,  and is former patent director and senior consultant at Albihns AB. He is  also a partner in Zacco Group, one of Europes leading consultant  companies in intellectual property law. He is presently active in Brolin  IP Services AB.

      Ivar Frischer

      Ivar Frischer

      Ivar Frischer

      Co-founder

      Member

      • Chief Designer Yovinn AB Fep 2012 -present
      • 2015Program Designer Volvo Car group at the DesignDepartment.    
      • 1999-2012 Cheif Designer SAAB Automobile 
      • Design Manager General Motors 2006-2008 GM Europe Aftersale Design team.

      Boris Klanger

      Ivar Frischer

      Boris Klanger

      Doctor

      Member

      • Director of Diabetes Clinic in Sweden. Operations manager since 2001.  Research at the Women's Clinic, Uppsala University. Items at Anatomical Inst. Scientific article published in the Journal of Adolescent Health Care, JAHC. Course in research methodology. Co-author of the dementia education "Dementia Steps".  Amanuensis at 

      Doctor

      Member

      • Director of Diabetes Clinic in Sweden. Operations manager since 2001.  Research at the Women's Clinic, Uppsala University. Items at Anatomical Inst. Scientific article published in the Journal of Adolescent Health Care, JAHC. Course in research methodology. Co-author of the dementia education "Dementia Steps".  Amanuensis at the Department of Anatomy, Department of Pharmacology, and Department of Physiology, Uppsala University. Supervised and examined medical students, prepared exam questions, corrected exams, held oral exams, etc.   Study counselor at the medical school in Uppsala. Supervisor for AT and ST doctors for many years, including supervisor training.  Recurring and frequent lecturer assignments in dementia / geriatrics: The aging person, AQT testing in dementia, cognitive screening battery in dementia, TIMY dementia. Other lectures in the field of dementia, including for the dementia association. Recurring and frequent lecturer assignments in diabetes (Lilly, NovoNordisk, MSD, GSK, AstraZeneca, Sanofi).

      Patrick Martinsson

      Founder/Inventor

      Member/Manager

       

      Type one diabetic.

      Founder and inventor of the MiniPen systems.

      Contact Us


      MedTech Concept LLC 

      919N, Market Street, 

      Suite 950,Wilmington, 

      Delaware, USA 


      Please send us a message or call us for an appointment. 



      Founder/Inventor

      Patrick Martinsson

      +46709988357 Whatsapp, Telegram

      Email: ​patrick@medtechconcept.com 



      MedTech Concept LLC

      Delaware, United States

      Send Message

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

      Cancel

      Copyright © 2019 MedTechConcept AB  All Rights Reserved.

      • Privacy Policy

      Powered by Patrick